Treatment decisions should be regularly reviewed to ensure ongoing clinical benefit and appropriate resource utilisation within NHS care pathways
References Jindal AK, Pilania RK, Prithvi A, Guleria S, Singh S (2019) Kawasaki disease: characteristics, diagnosis and unusual presentations
Do you think Amazon would be the next
How GLP-1 Medications Differ from Other Weight Loss Drugs: Traditional Weight Loss Medications: Stimulants (phentermine): Increase energy, suppress appetite through adrenaline-like effects Fat blockers (orlistat): Prevent fat absorption in intestines Combination pills (Contrave, Qsymia): Multiple mechanisms, moderate effectiveness These produce 3-9% average weight loss at best
Todays announcement builds upon our historic Most Favored Nations drug pricing deals goal of democratizing access to weight-loss medication, which has been out of reach for so many in need, CMS Administrator Mehmet Oz, MD, said in a statement in December 2025